Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

A miniaturized self-assembly pipette tip with restricted access mesoporous polypyrrole solid-phase extraction, combined with capillary electrophoresis with diode array detection (CE-DAD), was developed to rapidly extract and determine enalapril from urine samples. The CE-DAD technique used 50 mmol L phosphate (pH 7) as the background electrolyte, a voltage of 13 kV, a 30 mbar hydrodynamic injection for 4 s, a capillary temperature of 25°C, and a wavelength of 195 nm to achieve a migration time of 6.3 min with satisfactory peak asymmetry and no interfering and/or baseline noise. The factors that influenced the extraction efficiency were evaluated and optimized: 750 µL sample at pH 7.5, 40 mg adsorbent, 250 µL hexane as a washing solvent, and 750 µL acetonitrile as eluent, resulting in recoveries around 74%. Linearity was acceptable in the 100-3000 ng mL range, and the selectivity and accuracy were also suitable. The limits of detection and quantitation were 30 and 50 ng mL, respectively. The adsorbent effectively removed 87% of the proteins and may be reused three times. The analytical approach was successfully verified and used to analyze enalapril in urine samples collected from volunteers. Finally, the greenness of the researched technique was assessed using five measures that showed good eco-friendliness.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12039168PMC
http://dx.doi.org/10.1002/elps.8126DOI Listing

Publication Analysis

Top Keywords

enalapril urine
12
urine samples
12
self-assembly pipette
8
pipette restricted
8
restricted access
8
access mesoporous
8
mesoporous polypyrrole
8
polypyrrole solid-phase
8
solid-phase extraction
8
capillary electrophoresis
8

Similar Publications

We present a rare case of Galloway-Mowat syndrome (GAMOS) in an elderly patient with a WD repeat domain 73 (WDR73) gene deletion. A 64-year-old man with recurrent deep vein thrombosis on anticoagulation, intermittent atrial fibrillation, ulcerative colitis, apical hypertrophic cardiomyopathy, hypertension, and biopsy-proven membranous nephropathy (MN) presented with urinary frequency associated with frothing. His physical examination was unremarkable.

View Article and Find Full Text PDF

Background: Lipoprotein glomerulopathy (LPG), a rare genetic metabolic kidney disease with poor prognosis, is caused by mutations in the apolipoprotein E (ApoE) gene and is usually accompanied by hyperlipidemia. Lipoprotein glomerulopathy can be complicated by other glomerulopathies, such as membranous nephropathy, lupus nephritis, and immunoglobulin A nephropathy (IgAN), which have been mainly reported in Japan. Herein, we present the first case of a patient with LPG with IgAN from Chongqing, China.

View Article and Find Full Text PDF

A miniaturized self-assembly pipette tip with restricted access mesoporous polypyrrole solid-phase extraction, combined with capillary electrophoresis with diode array detection (CE-DAD), was developed to rapidly extract and determine enalapril from urine samples. The CE-DAD technique used 50 mmol L phosphate (pH 7) as the background electrolyte, a voltage of 13 kV, a 30 mbar hydrodynamic injection for 4 s, a capillary temperature of 25°C, and a wavelength of 195 nm to achieve a migration time of 6.3 min with satisfactory peak asymmetry and no interfering and/or baseline noise.

View Article and Find Full Text PDF

Background Nephrotic syndrome (NS) is a common renal ailment among children, typically manifesting as a relapsing-remitting pattern. Most of the cases are managed on an outpatient basis, but a subset of patients experience complications, e.g.

View Article and Find Full Text PDF

Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure.

J Am Coll Cardiol

June 2024

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: https://twitter.com/mvaduganathan.

Background: The Kidney Disease Improving Global Outcomes (KDIGO) classification integrates both estimated glomerular filtration rate and urine-albumin-creatinine ratio to stratify risk more comprehensively in patients with chronic kidney disease. There are limited data assessing whether this classification system is associated with prognosis and treatment response in heart failure populations.

Objectives: The aim of this study was to evaluate the relative treatment effects of sacubitril/valsartan across the KDIGO risk categories in patients with HFrEF.

View Article and Find Full Text PDF